Unraveling systemic responses to NQO1-activated IB-DNQ and Rucaparib single and dual agent therapy in triple-negative breast cancers
Avery M. Runnebohm(Indiana University School of Medicine), Amber L. Mosley(MRC Laboratory of Molecular Biology)
Cited by 0
Related Papers
The Exosome Component Rrp6 Is Required for RNA Polymerase II Termination at Specific Targets of the Nrd1-Nab3 Pathway
|PLoS Genetics|2015|65
Loss of succinyl-CoA synthetase in mouse forebrain results in hypersuccinylation with perturbed neuronal transcription and metabolism
|Cell Reports|2023|23
A human skeletal muscle stem/myotube model reveals multiple signaling targets of cancer secretome in skeletal muscle
|iScience|2023|9
RNA Polymerase II CTD phosphatase Rtr1 prevents premature transcription termination
|bioRxiv (Cold Spring Harbor Laboratory)|2019|0